| No. |
Proposition |
|
For |
Against |
Abstain |
| 1 |
DIRECTOR Jessica Hopfield, Ph.D. |
|
|
|
|
| 2 |
DIRECTOR David T. Scadden, M.D. |
|
|
|
|
| 3 |
To approve, on an advisory basis, the compensation paid to the Companys named executive officers. |
|
|
|
|
| 4 |
To approve, on an advisory basis, the frequency of future advisory votes on the compensation paid to the Companys named executive officers. |
|
|
|
|
| 5 |
To approve an amendment and restatement of the Companys 2015 Stock Incentive Plan. |
|
|
|
|
| 6 |
To adopt and approve an amendment to the Companys Restated Certificate of Incorporation to increase the number of authorized shares of the Companys capital stock from 200,000,000 to 395,000,000 and the number of authorized shares of the Companys common stock from 195,000,000 to 390,000,000. |
|
|
|
|
| 7 |
To ratify the appointment of Ernst & Young LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2025. |
|
|
|
|